Precigen Inc (PGEN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.54B
Last updated: Nov 17, 2026 at 4:33 PM ET
Precigen Inc (PGEN) Statistics
Precigen (PGEN) has a market cap of $1.54B and an enterprise value of $1.62B. Revenue grew 2691.26% over the last 12 months from the 12 months before. Its share count is up 16.63% from a year earlier.
Total Valuation
Enterprise value is 5.14% above the market cap, as debt exceeds cash.
| Market Cap | $1.54B |
|---|---|
| Enterprise Value | $1.62B |
| Latest price (Nov 17, 2026) | $4.29 |
Key Dates
The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 9.8x and 18.3x.
| P/E Ratio | 98.4x |
|---|---|
| Forward P/E | 17.9x |
| P/S Ratio | 9.8x |
| Forward P/S | 6.4x |
| P/B Ratio | 18.3x |
| P/TBV Ratio | 23.2x |
Enterprise Valuation
Counting debt and cash, the company is valued at 42.2x EBITDA.
| EV / Earnings | 66.4x |
|---|---|
| EV / Sales | 10.4x |
| EV / EBITDA | 42.2x |
| EV / EBIT | 47.7x |
Price Statistics
The stock is down 11.55% over 52 weeks and trades 35.29% below its 50-day average.
| Beta (1Y) | 1.71 |
|---|---|
| 52-Week Change | -11.55% |
| 1-Month Change | -35.59% |
| 3-Month Change | -40.08% |
| 6-Month Change | +3.13% |
| 5-Year Change | +43.69% |
| 10-Year Change | -73.41% |
| Total Return (1Y) | -11.55% |
| Total Return (3Y CAGR) | +53.75% |
| Total Return (5Y CAGR) | +2.78% |
| Return vs SPY (1Y) | -23.11% |
| Max Drawdown (1Y) | -50.70% |
| Max Drawdown (3Y) | -64.17% |
| Sharpe Ratio (1Y) | -0.15 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $6.63 |
| 200-Day Average | $5.28 |
| 52-Week Range | $3.04 to $8.98 |
| RSI (14 Days) | 32.1 |
| Average Volume (20 Days) | 7.79M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.58x current liabilities, and total debt is 1.12x shareholder equity.
| Current Ratio | 5.58x |
|---|---|
| Quick Ratio | 4.83x |
| Debt / Equity | 1.12x |
| Debt / EBITDA | 2.46x |
| Interest Coverage | 2.88x |
Returns and Efficiency
Return on invested capital is 18.93% and return on equity is 29.13% over the last 12 months.
| Return on Equity (ROE) | 29.13% |
|---|---|
| Return on Assets (ROA) | 11.51% |
| Return on Invested Capital (ROIC) | 18.93% |
| Return on Capital Employed (ROCE) | 18.74% |
| ROA (5Y Average) | -64.19% |
| Asset Turnover | 0.81x |
| Inventory Turnover | 0.62x |
| Receivables Turnover | 1.85x |
| Cash Conversion Cycle | 615 days |
Taxes
Income tax took 0.81% of pretax income over the last 12 months.
| Income Tax (TTM) | $200.00K |
|---|---|
| Effective Tax Rate | 0.81% |
Scores
PGEN has an Altman Z-Score of -5.89, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -5.89 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $156.09M over the last 12 months.
| Revenue | $156.09M |
|---|---|
| Revenue Growth (YoY) | +2691.26% |
| Gross Profit | $142.62M |
| Operating Income | $33.63M |
| Pretax Income | $24.61M |
| Net Income | $24.41M |
| EBITDA | $38.34M |
| EBIT | $33.99M |
| Reported EPS (TTM) | $0.04 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 39.50% of the $212.10M in total assets.
| Cash and Equivalents | $14.96M |
|---|---|
| Total Debt | $94.26M |
| Net Debt | $79.30M |
| Net Debt Per Share | $0.22 |
| Working Capital | $140.97M |
| Shareholder Equity | $83.79M |
| Book Value Per Share | $0.23 |
| Tangible Book Value | $66.33M |
| Tangible Book Per Share | $0.19 |
| Total Assets | $212.10M |
| Total Liabilities | $128.31M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.10M of capital spending, operating cash flow left -$74.32M of free cash flow.
| Operating Cash Flow | -$73.21M |
|---|---|
| Capital Expenditures | $1.10M |
| Free Cash Flow | -$74.32M |
| FCF Per Share | -$0.21 |
| Depreciation and Amortization | $5.26M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 21.55%.
| Gross Margin | 91.37% |
|---|---|
| Operating Margin | 21.55% |
| Pretax Margin | 15.76% |
| Net Margin | 15.64% |
| EBITDA Margin | 24.56% |
| EBIT Margin | 21.77% |
| FCF Margin | -47.61% |
| Gross Margin (5Y Average) | 35.87% |
Growth
Revenue fell 28.87% a year over 3 years.
| Revenue Growth (3Y CAGR) | -28.87% |
|---|---|
| Revenue Growth (5Y CAGR) | -21.26% |
| Book Value Per Share Growth (2Y CAGR) | -62.54% |
| Tangible Book Per Share Growth (2Y CAGR) | -80.30% |
Dividends and Yields
PGEN does not pay a dividend. Its free cash flow yield is -4.84%.
| Earnings Yield | 1.02% |
|---|---|
| FCF Yield | -4.84% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
Peer Position
Against 10 similar companies, PGEN has the 7th highest P/S.
P/S RatioPeer median 19.5x
ROICPeer median -57.88%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +23.09%
| P/S Ratio | 9.8x vs 19.5x median |
|---|---|
| ROIC | 18.93% vs -57.88% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +2691.26% vs +23.09% median |
Analyst Forecast
Consensus estimates put revenue growth at 575.57% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +575.57% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PGEN
What is PGEN's market cap?
Precigen has a market cap of $1.54B. Its enterprise value, which adds debt and subtracts cash, is $1.62B.
What is PGEN's P/E ratio?
Precigen has a trailing P/E ratio of 98.4x and a forward P/E of 17.9x.
How many shares of PGEN are outstanding?
Precigen has 358.25M shares outstanding. The count is up 16.63% from a year earlier.
Does PGEN pay a dividend?
No. Precigen does not pay a dividend.
How much debt does PGEN have?
Precigen has $94.26M of total debt and $14.96M of cash and equivalents, a net debt position of $79.30M.
PGEN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors